Loading ...WHO Partners With Argentine Biotech Firm to Develop mRNA Bird Flu Vaccine
Argentine bird flu vaccine developer Sinergium Biotech will share the “technology, materials and expertise” behind its mRNA bird flu vaccine, to ensure an “equitable” global vaccine rollout should a global bird flu pandemic develop, the WHO announced Monday.
“This initiative exemplifies why WHO established the mRNA Technology Transfer Programme — to foster greater research, development and production in low- and middle-income countries, so that when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response,” said WHO Director-General Tedros Adhanom Ghebreyesus, in a statement.